French clinical-stage biotechnology company Enterome SA has raised US$19 million in private financing to advance its lead OncoMimics™ immunotherapy candidate EO2463 for treating indolent non-Hodgkin lymphoma, with particular focus on patients in the “watch-and-wait” category who currently lack approved treatment options.
German biotech company osteolabs GmbH has secured a pivotal distribution partnership with leading Swiss medical laboratory ‘labor team’, bringing cutting-edge calcium isotope technology to Switzerland and Liechtenstein’s healthcare systems and with the aim of transforming bone health diagnostics for over half a million patients.
Biotechnology giant Biogen has entered into a strategic research partnership with privately held City Therapeutics to develop novel RNA interference-based therapeutics for central nervous system diseases, combining next-generation RNAi engineering with proprietary drug delivery technologies.
F. Hoffmann-La Roche has announced an ambitious US$50 billion investment initiative spanning five years, designed to transform the company’s United States pharmaceutical and diagnostics infrastructure. The comprehensive expansion programme addresses critical manufacturing bottlenecks whilst establishing cutting-edge research capabilities across multiple therapeutic domains, creating over 12,000 new positions in the biomedical technology sector.
Austrian biotech Solgate has achieved a significant milestone in pharmaceutical research by deploying precision automated liquid handling systems to unlock therapeutic potential in solute carrier transporters, targeting one of medicine’s most underexplored protein families that orchestrate cellular traffic and drive diverse disease mechanisms.
Fujifilm Corporation has announced a comprehensive rebranding of its life sciences subsidiaries, positioning the conglomerate as a unified provider of end-to-end pharmaceutical development solutions. The strategic restructuring affects two major subsidiaries and reflects the company’s substantial investment commitment to the biotechnology sector.
Astoriom, a leading provider of R&D sample stability and biorepository storage services, has appointed Ryan Smith as Global Head of Sales in a strategic move to accelerate its commercial operations across key international markets. The appointment reflects the company’s commitment to scaling its portfolio of specialised storage solutions as pharmaceutical and biotechnology organisations face increasing […]
Indian biopharmaceutical company Shilpa Biocare has established a strategic commercial supply agreement with Finland’s Orion Corporation, positioning its innovative recom- binant human albumin for European market entry ahead of the BIO Boston conference.
WHX LABS DUBAI, February 9 – 12, 2026 Dubai, UAE www.worldhealthexpo.com
Labquality Days February 5 – 6, 2026 Helsinki, Finland
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
